Aixin Life International Inc (AIXN) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Aixin Life International Inc   (AIXN)

Select the Financial Report: Select the Period:


Description of Aixin Life International Inc's Business Segments
The registrant operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. The Direct Sales segment involves direct product sales to customers and generated $171,949 in revenue for 2025, a 66% decrease from 2024. The Pharmacy segment includes sales at pharmacies, with revenue of $107,198 in 2025, down 87% from 2024. The Hotel segment encompasses hotel operations, generating $408,581 in revenue for 2025, a 30% decline from 2024. The Manufacture and Sale segment covers manufacturing and sales activities, with revenue of $801,699 in 2025, a 58% decrease from 2024. The Chief Executive Officer, serving as the chief operating decision maker, evaluates these segments based on their discrete financial information to allocate resources and assess performance.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Aixin Life International Inc Revenues by Segments
 
Product    4.55 % of total Revenue
Pharmacy    5.61 % of total Revenue
Hotel    44.89 % of total Revenue
Manufacture and Sale    44.96 % of total Revenue
Shengcaofeng Health Industry Yunnan Co Ltd    59.36 % of total Revenue
Chengdu Lisheng Huiren Pharmacy Co Ltd    0.01 % of total Revenue
Chengdu Aixin International Travel Service Co Ltd    5.68 % of total Revenue

Q3 three months ended (Sep 30 2025)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Product 0.01 4.55 %
Pharmacy 0.02 5.61 %
Hotel 0.14 44.89 %
Manufacture and Sale 0.14 44.96 %
Shengcaofeng Health Industry Yunnan Co Ltd 0.18 59.36 %
Chengdu Lisheng Huiren Pharmacy Co Ltd 0.00 0.01 %
Chengdu Aixin International Travel Service Co Ltd 0.02 5.68 %
Total 0.30 100 %




Q3 three months ended (Sep 30 2025)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Product -86.58 % -56.17 %
Pharmacy -93.65 % -35.96 %
Hotel -28.98 % 20.62 %
Manufacture and Sale -63.94 % -53.31 %
Shengcaofeng Health Industry Yunnan Co Ltd 478.65 % -12.01 %
Chengdu Lisheng Huiren Pharmacy Co Ltd - -
Chengdu Aixin International Travel Service Co Ltd 202.08 % 389.98 %
Total -67.75 % -34.48 %




Q3 three months ended (Sep 30 2025)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Product 0.00 1.09 %
Pharmacy -0.08 -
Hotel -0.18 -
Manufacture and Sale -0.09 -
Total -0.34 -




Q3 three months ended (Sep 30 2025)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Product - -
Pharmacy - -
Hotel - -
Manufacture and Sale - -
Total - -




Annual Report on Aixin Life International Inc Divisions, Sales by Country

 
Product   Product Segment contribution to total sales 11.54 % of total Revenue
Pharmacy   Pharmacy Segment contribution to total sales 7.2 % of total Revenue
Hotel   Hotel Segment contribution to total sales 27.43 % of total Revenue
Manufacture and Sale   Manufacture and Sale Segment contribution to total sales 53.83 % of total Revenue
Shengcaofeng Health Industry Yunnan Co Ltd   Shengcaofeng Health Industry Yunnan Co Ltd Segment contribution to total sales 44.09 % of total Revenue
Chengdu Lisheng Huiren Pharmacy Co Ltd   Chengdu Lisheng Huiren Pharmacy Co Ltd Segment contribution to total sales 0.05 % of total Revenue
Chengdu Aixin International Travel Service Co Ltd   Chengdu Aixin International Travel Service Co Ltd Segment contribution to total sales 0.31 % of total Revenue
Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd   Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd Segment contribution to total sales 0.25 % of total Revenue


Twelve months ended 2025
AIXN s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Product 0.17 11.54 %
Pharmacy 0.11 7.2 %
Hotel 0.41 27.43 %
Manufacture and Sale 0.80 53.83 %
Shengcaofeng Health Industry Yunnan Co Ltd 0.66 44.09 %
Chengdu Lisheng Huiren Pharmacy Co Ltd 0.00 0.05 %
Chengdu Aixin International Travel Service Co Ltd 0.00 0.31 %
Total 1.49 100 %
Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd 0.00 0.25 %


Twelve months ended 2025
AIXN s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Product -0.84 -
Pharmacy -0.24 -
Hotel -0.99 -
Manufacture and Sale -0.46 -
Total -2.04 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Product -65.89 % -
Pharmacy -86.97 % -
Hotel -30.23 % -
Manufacture and Sale -58.06 % -
Chengdu Lisheng Huiren Pharmacy Co Ltd -98.7 % -
Chengdu Aixin International Travel Service Co Ltd 43.52 % -
Total -61.05 % -
Sichuan Aixintang Xinfu Pharmacy Chain Co Ltd -83.54 % -
Pharmacies - -
Yuefu Restaurant - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.